Hammarsten, Peter
Cipriano, Mariateresa
Josefsson, Andreas; et al.
|
Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression
PLoS ONE,
7(10): e47994-
|
2012
|
Hämta
|
Thomasson, Marcus
Wang, Baofeng
Hammarsten, Peter; et al.
|
LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer.
International Journal of Cancer,
128(12): 2843-2852
|
2011
|
-
|
Josefsson, Andreas
Adamo, Hani
Hammarsten, Peter; et al.
|
Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome
American Journal of Pathology,
179(4): 1961-1968
|
2011
|
-
|
Thors, Lina
Bergh, Anders
Persson, Emma; et al.
|
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4
PLoS ONE,
5(8): e12275-
|
2010
|
Hämta
|
Hammarsten, Peter
Karalija, Amar
Josefsson, Andreas; et al.
|
Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Clinical Cancer Research,
16(4): 1245-1255
|
2010
|
-
|
Johansson, Anna
Rudolfsson, Stina
Hammarsten, Peter; et al.
|
Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy
American Journal of Pathology,
177(2): 1031-1041
|
2010
|
-
|
Hägglöf, Christina
Hammarsten, Peter
Josefsson, Andreas; et al.
|
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival
PLoS ONE,
5(5): e10747-
|
2010
|
-
|
Fowler, Christopher J
Hammarsten, Peter
Bergh, Anders
|
Tumour cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer
PLoS ONE,
5(12): e15205-
|
2010
|
-
|
Chung, Sui Chu
Hammarsten, Peter
Josefsson, Andreas; et al.
|
A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
European Journal of Cancer,
45(1): 174-182
|
2009
|
-
|
Hammarsten, Peter
Rudolfsson, Stina
Henriksson, Roger; et al.
|
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats.
Prostate,
67(6): 573-581
|
2007
|
-
|
